New cancer ‘tracer’ could speed up tumor detection

Date:

Related stories

World water day

Global (Commonwealth Union) - World Water Day is an...

  Study shows new method of clearing toxins associated to Alzheimer’s disease

Science & Technology, Singapore (Commonwealth Union) - Alzheimer's disease...

Increased caffeine may lower weight and type 2 diabetes risk

Science & Technology, UK (Commonwealth Union) - Caffeine is...

Newfangled semiconductors for 5G and 6G in India

(Commonwealth) _ Polymatech Electronics, a leading semiconductor chip manufacturer,...

Preterm babies not accustomed to repetition in pain

Science & Technology, UK (Commonwealth Union) - Preterm babies,...

Canada (Commonwealth Union) – For people in line for imaging tests to diagnose neuroendocrine cancer, time is essential. Presently researchers at the University of Alberta (U of A), have put together a new medical imaging agent for positron emission tomography (PET) scans that may lower waiting times, and be more economical to produce and potentially indicate more of some types of cancer tumors.

Ralf Schirrmacher, an oncology imaging professor, and his team at the Medical Isotope and Cyclotron Facility on the U of A’s South Campus were applying a state-of-the-art cyclotron — a machine that currently gives the province medical isotopes utilized in diagnostic scans, to produce a new imaging compound showing cancer tumors when patients undergo a PET or PET-MRI scan.

The application of highly minor amounts of radioactive material as diagnostic “tracers” for cancer imaging is not new. However, researchers continue their work on new chemistries to ensure these radiotracers have increased safety, reliability and effectiveness. The new radiotracer, marked with fluorine-18, is effective in locating neuroendocrine tumors, which are cancerous tumors that may appear in any part of the body but are frequently detected in the intestines, lungs, pancreas and stomach.

Schirrmacher stated that fluorine-18 is an enhancement compared with other presently utilized radioisotopes such as gallium-68. Radioactive gallium needs a special generator. Another issue is that there are regular supply limitations and use of the gallium generator is restricted to a certain level, resulting in only 2 to 3 patients per day able to get a medical scan.

“The radioactive peptides are labelled capitalizing on the very strong bond between silicon and fluorine. The chemistry works at room temperature, and purification only requires one simple extraction and the imaging agent is ready for injection – this is why it is so stable and reliable,” said Schirrmacher, further stating that he will not license the chemical procedure making it available for everyone.

Subscribe

Stay up to date with the latest news from the Commonwealth Union

Latest stories

Electronic Genset launched by Su-vastika in India

(Commonwealth) _ Su-vastika, a leading manufacturer of power solutions,...

Killing cancer cells with bacteria

Science & Technology, Australia (Commonwealth Union) – A new...

Citizen scientist’s role for native plants

Science & Technology, Australia (Commonwealth Union) – A new...

After months of trepidation, Sri Lanka gets the much-awaited IMF Bailout

Colombo Sri Lanka (Commonwealth Union)_The much-awaited and anticipated bailout...

Official Sri Lanka Launch of the Commonwealth Union Media Portal .

The official Sri Lankan launch of the Commonwealth Union...

LEAVE A REPLY

Please enter your comment!
Please enter your name here